Turner Christopher Durant (CIK 1862146) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-15). Recent activity: Sell NUVL (31,530 shares), Sell NUVL (41,100 shares), Buy NUVL (14,350 shares), Sell NUVL (14,350 shares), Sell NUVL (871 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-15 | Nuvalent, Inc. (NUVL) | Chief Medical Officer | Sell | 31,530 | $3.9M |
| 2026-07-15 | Nuvalent, Inc. (NUVL) | Chief Medical Officer | Sell | 41,100 | $0 |
| 2026-07-15 | Nuvalent, Inc. (NUVL) | Chief Medical Officer | Buy | 14,350 | $0 |
| 2026-07-15 | Nuvalent, Inc. (NUVL) | Chief Medical Officer | Sell | 14,350 | $0 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Medical Officer | Sell | 871 | $83,668 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Medical Officer | Sell | 1,119 | $108,375 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Medical Officer | Sell | 1,929 | $188,965 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Medical Officer | Sell | 317 | $31,231 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Medical Officer | Sell | 1,321 | $127,807 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Medical Officer | Sell | 1,635 | $159,135 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Medical Officer | Sell | 225 | $22,140 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Medical Officer | Buy | 17,500 | $0 |
Source: SEC Form 4 filings · as of 2026-07-15